Axa S.A. Immuno Gen, Inc. Transaction History

Axa S.A.

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$3.75 - $20.05 $44,625 - $238,595	11,900 Added 36.17%	44,800 $845,000
Q1 2023 May 15, 2023	BUY	$3.67 - $4.92 $120,743 - $161,868	32,900 New	32,900 $126,000
Q4 2021 Feb 14, 2022	SELL	$4.75 - $7.5 $1.28 Million - $2.01 Million	-268,500 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$5.02 - $6.59 $1.06 Million - $1.4 Million	212,100 Added 376.06%	268,500 $1.52 Million
Q3 2020 Nov 13, 2020	SELL	$3.45 - $4.89 $352,935 - $500,246	-102,300 Reduced 64.46%	56,400 $203,000
Q1 2020 May 15, 2020	BUY	$2.12 - $6.8 $184,652 - $592,280	87,100 Added 121.65%	158,700 $541,000
Q4 2019 Feb 18, 2020	BUY	$2.25 - $5.8 $161,100 - $415,280	71,600 New	71,600 $366,000
Q2 2019 Aug 13, 2019	SELL	$1.8 - $3.3 $55,339 - $101,455	-30,744 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$2.41 - $5.91 $60,491 - $148,341	-25,100 Reduced 44.95%	30,744 $83,000
Q4 2018 Feb 13, 2019	BUY	$3.94 - $9.7 $220,025 - $541,686	55,844 New	55,844 $268,000
Q3 2018 Nov 08, 2018	SELL	$8.6 - $11.26 $172,060 - $225,278	-20,007 Closed	0 $0
Q2 2018 Aug 13, 2018	BUY	$9.52 - $12.15 $13,927 - $17,775	1,463 Added 7.89%	20,007 $195,000
Q1 2018 May 14, 2018	SELL	$6.7 - $12.95 $1.09 Million - $2.11 Million	-162,856 Reduced 89.78%	18,544 $195,000
Q4 2017 Feb 13, 2018	BUY	$5.07 - $7.92 $508,014 - $793,584	100,200 Added 123.4%	181,400 $1.16 Million
Q3 2017 Nov 13, 2017	BUY	$5.4 - $8.47 $438,480 - $687,764	81,200	81,200 $621,000

1.41M

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

Get notified when there are updates to the investment portfolio of Axa S.A., based on Form 13F filings with the SEC.

Stay updated on Axa S.A. with notifications on news.